Morning Medical with Dr. Chow
A daily update covering the latest medical & health news from around the world using artificial intelligence. Doctor Chi-Ming Chow is a family physician, general internist, and cardiologist. He is also a Professor of Medicine at the University of Toronto.
Cyclospora in Canada, Oral PCSK9 Inhibitor, and Carfentanil Overdose Concerns
In this episode, Dr. Chi-Ming Chow covers the cyclosporiasis situation in Canada, sharing the Public Health Agency's stance and prevention tips. He discusses the FDA's approval of enlicitide, an oral PCSK9 inhibitor, and its clinical results, adherence, side effects, and safety. The episode examines Montreal's carfentanil overdose deaths and Quebec's overdose increase, alongside the public health response. Dr. Chow also explores England's ban on high-caffeine energy drinks for children and its enforcement. Additionally, he addresses the Cyclospora outbreak linked to Taco Bell lettuce, its impact in Michigan, and responses from Taco Bell and Taylor Farms, concluding with food safety advice.
Key Points
- Cyclosporiasis cases in Canada have seen a rise, particularly linked to travel, but there is no direct connection to the significant outbreak in the United States.
- The FDA has approved enlicitide, the first oral PCSK9 inhibitor pill for lowering cholesterol, providing a non-invasive alternative to injectable treatments.
- Montreal Public Health has issued a warning about a surge in overdose deaths linked to the potent synthetic opioid carfentanil, highlighting the ongoing public health crisis.
Chapters
| 0:00 | |
| 2:52 | |
| 3:33 | |
| 5:33 | |
| 6:32 | |
| 8:08 | |
| 8:52 | |
| 10:24 | |
| 11:44 | |
| 13:18 | |
| 14:32 |
Transcript
Loading transcript...
- / -